doc_id,table_id,row_index,ColumnA,ColumnB,ColumnC
WHO_TB_handbook_module3_diagnosis_2025,Table 2.7.,1,Purpose,,Detection of resistance to first-line and/or second-line TB drugs
WHO_TB_handbook_module3_diagnosis_2025,Table 2.7.,2,Principle of action,,"DNA-based reverse hybridization, or line probe, assays"
WHO_TB_handbook_module3_diagnosis_2025,Table 2.7.,3,Complexity,Reagents,Reagents are available within standardized kits and may have temperature requirements for storage
WHO_TB_handbook_module3_diagnosis_2025,Table 2.7.,4,,Skills,"Advanced technical skills (i.e. multiple sample or reagent handling steps, precision pipetting, molecular workflows may be required)"
WHO_TB_handbook_module3_diagnosis_2025,Table 2.7.,5,,Pipetting,Multiple precision pipetting steps required by the procedure
WHO_TB_handbook_module3_diagnosis_2025,Table 2.7.,6,,Testing procedure,May require multiple specimen treatment steps before transferring the specimen into a sealed container for multistep testing Manual or automated DNA extraction Manual or automated real-time PCR Instrument-based reverse hybridization
WHO_TB_handbook_module3_diagnosis_2025,Table 2.7.,7,Type of test result reporting,,Manual
WHO_TB_handbook_module3_diagnosis_2025,Table 2.7.,8,Setting of use,,Molecular laboratory (special infrastructure and separate spaces for different parts of the testing procedure are required)